Out Patient Service
Research:
- Details
- Last Updated on Friday, 30 September 2022 11:19
Extramural Grants:
- Cancer Awareness and Referral Engagement (CARE) program for medical- officers/Specialists in selected district hospitals of Haryana. – (Pfizer Global Medical Grant) PI: Dr Hari Sagiraju.
- Assessment of Breast cancer risk profile and factors implicit in differential incidence rates within rural and urban populations in India by developing a machine learning-based risk prediction tool. (ICMR Ad-hoc Grant) PI: Dr Jitendra Kr Meena
- Screening for risk factors and precancerous lesions of head & neck and prostate cancers in the geographical areas near National Cancer Institute-India (Bayer India Scientific Research Grant). PI: Dr Hari Sagiraju.
Intramural Grants:
- Assessment of Second-Hand Tobacco smoke (SHS) exposure and evaluation of mHealth promotion strategy among attendants of cancer patients at a tertiary cancer hospital. – AIIMS Intramural grant PI: Dr Jitendra Kr Meena.
- “Topoisomerase2β and Anthracycline induced Cardio Toxicity (TACT) among females treated for malignant breast tumors.” – AIIMS Intramural grant PI: Dr Hari Sagiraju
- To evaluate the mutation detection performance of various BRCA testing eligibility criteria tools among Indian females with breast cancer and in their immediate family members. – AIIMS Interdisciplinary Intramural grant PI: Dr Hari Sagiraju
Events
- Details
- Last Updated on Wednesday, 28 September 2022 10:20
Events:
| AIIMS Employee cancer awareness and Screening (Aug 22 to Sep 2, 2022)
|
 |
| Workshop on Cancer Awareness and Early Detection and Cancer screening camp at India International Center, New Delhi
28th May, 2022
|
 |
| Tobacco Symposium:
Tobacco cessation Interventions in Oncology Practice 11th March, 2020
|
 |
| World Cancer Day
Feb 4th 2020 “Role of Nurses in Cancer Prevention and Control.” Training for Nurses |
 |
Faculty
- Details
- Last Updated on Wednesday, 28 September 2022 10:20
|
Dr. Hari Krishna Raju Sagiraju, MD MPH PhD Assistant Professor, Preventive Oncology-NCI, Jhajjar
|
|
Areas of Interest: 1. Cancer Epidemiology and Biostatistics 2. Familial cancer Risk assessment and genetic counselling. 3. Implementation research and population cancer control strategies. 4. Cancer registry development
|
|
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. Office: Room No 3, 1st Floor Academic Block, NCI-Jhajjar Ph: 01251- 274790 OPD days (Preventive Oncology Clinic NCI): Monday, Wednesday, Thursday |
|
Dr Jitendra Kumar Meena, MD DNB ACME Assistant Professor, Preventive Oncology-NCI, Jhajjar
|
|
Areas of Interest:
|
|
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. Office: Room No 2, 1st Floor Academic Block, NCI-Jhajjar Ph: 01251-274785 OPD days (Preventive Oncology Clinic-NCI): Tuesday, Wednesday, Friday |
Clinical Services
- Details
- Last Updated on Wednesday, 28 September 2022 10:20
Clinical Services:
Preventive oncology clinic
3rd Floor, B-Wing OPD Block, NCI-Jhajjar
Monday to Friday, 9am to 1PM
For appointments: 8929042745
Introduction:
- Details
- Last Updated on Wednesday, 28 September 2022 12:53
|
Preventive Oncology NCI:
Preventive oncology includes measures that are taken to prevent the development or delay progression of cancer. Cancer prevention is taken on three major levels: A). Primary Cancer Prevention: It focuses on health promotion, identifying causative factors and reducing the risk of cancer. For example, alcohol and tobacco cessation, weight reduction, vaccination, healthy lifestyle, etc. B) Secondary Cancer Prevention: It focuses on early cancer detection through screening before the onset of symptoms when the cancers are likely to be treated successfully. For example, mammography, HPV-DNA test, oral visual inspection, PSA test, etc. C) Tertiary Cancer Prevention: It focuses on delaying the progression and preventing the complications like secondary malignancies after cancer diagnosis. Why it's important: Cancer prevention is done at both individual and community level for reducing the risk and incidence of cancer. By preventing cancer, the number of new cases of cancer will be lowered and thus reducing overall cancer burden. Early diagnosis will lead to optimal cancer management and improved survival. Preventive Oncology at NCI-Jhajjar envisages to develop evidence-based approaches and technical resources for cancer prevention and control in India through:
|
Contact Us
All India Institute of Medical Sciences
Ansari Nagar, New Delhi - 110029
Board Number : +91-11-26588500 / 26588700
Fax : +91-11-26588663 / 26588641
Important Links
